Illumina, Inc.

ILMN

$113.96

Name : Illumina, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $17,515,651,072.00

EPSttm : 5.45

Illumina, Inc.

$113.96

2.08%

$2.42

Float Short %

5.59

Margin Of Safety %

Put/Call OI Ratio

0.57

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.7

Price

116.33

Target Price

135.32

Analyst Recom

2.46

Performance Q

-4.39

Relative Volume

1.08

Beta

1.47

Ticker: ILMN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-13	ILMN	146.93	0.40	0.70	53062
2026-01-14	ILMN	143.92	0.42	0.40	53456
2026-01-15	ILMN	145.34	0.42	1.03	53617
2026-01-16	ILMN	141.64	0.42	0.31	53664
2026-01-20	ILMN	147.17	0.46	0.38	21407
2026-01-21	ILMN	152.54	0.45	1.15	21905
2026-01-22	ILMN	153.99	0.45	1.10	22111
2026-01-23	ILMN	150.36	0.45	0.22	22315
2026-01-26	ILMN	153.4	0.46	0.29	22354
2026-01-27	ILMN	152.12	0.46	0.83	22592
2026-01-28	ILMN	149.92	0.46	0.27	22573
2026-01-29	ILMN	149.66	0.46	0.21	22575
2026-01-30	ILMN	144.76	0.46	1.16	22660
2026-02-02	ILMN	141.11	0.47	0.59	22938
2026-02-03	ILMN	135.34	0.46	0.86	22810
2026-02-05	ILMN	133.55	0.49	1.00	23652
2026-02-09	ILMN	117.24	0.50	0.33	26220
2026-02-10	ILMN	119.31	0.56	0.65	25210
2026-02-11	ILMN	116.38	0.57	0.03	25708
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-13	ILMN	147.00	41.1	60.5	4.71
2026-01-14	ILMN	143.92	41.1	30.0	4.71
2026-01-15	ILMN	145.32	41.1	59.9	4.71
2026-01-16	ILMN	141.64	43.1	25.7	4.71
2026-01-20	ILMN	147.13	43.1	88.9	4.71
2026-01-21	ILMN	152.51	43.1	86.6	4.71
2026-01-22	ILMN	153.98	43.1	60.4	4.71
2026-01-23	ILMN	150.19	43.1	26.4	4.71
2026-01-26	ILMN	153.00	44.0	68.6	4.71
2026-01-27	ILMN	152.17	44.0	45.3	4.71
2026-01-28	ILMN	150.04	45.0	37.3	4.71
2026-01-29	ILMN	149.64	45.0	49.2	4.71
2026-01-30	ILMN	144.74	45.0	17.9	4.71
2026-02-02	ILMN	141.14	45.0	25.6	4.71
2026-02-03	ILMN	135.34	45.0	10.2	4.71
2026-02-04	ILMN	134.02	45.0	40.4	4.71
2026-02-05	ILMN	133.51	45.0	45.7	4.71
2026-02-06	ILMN	119.67	45.0	-52.0	4.71
2026-02-09	ILMN	117.25	16.9	30.0	5.07
2026-02-10	ILMN	119.32	9.1	68.3	5.14
2026-02-11	ILMN	116.33	9.1	25.6	5.14
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-13	ILMN	-0.01	1.32	4.58
2026-01-14	ILMN	-0.01	1.32	4.58
2026-01-15	ILMN	-0.01	1.32	4.58
2026-01-16	ILMN	-0.01	1.32	4.58
2026-01-20	ILMN	-0.01	1.65	4.58
2026-01-21	ILMN	-0.01	1.65	4.58
2026-01-22	ILMN	-0.01	1.65	4.58
2026-01-23	ILMN	-0.01	1.65	4.58
2026-01-26	ILMN	-0.01	2.03	4.58
2026-01-27	ILMN	-0.01	2.03	4.58
2026-01-28	ILMN	-0.01	2.03	4.35
2026-01-29	ILMN	-0.01	2.03	4.35
2026-01-30	ILMN	-0.01	2.03	4.35
2026-02-02	ILMN	-0.01	1.73	4.35
2026-02-03	ILMN	-0.01	1.73	4.35
2026-02-04	ILMN	-0.01	1.73	4.35
2026-02-05	ILMN	-0.01	1.73	4.35
2026-02-06	ILMN	-0.01	1.73	4.35
2026-02-09	ILMN	-0.01	1.49	4.35
2026-02-10	ILMN	-0.01	1.49	4.35
2026-02-11	ILMN	-0.00	1.49	5.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

1.06

Avg. EPS Est. Next Quarter

1.24

Insider Transactions

Institutional Transactions

1.49

Beta

1.47

Average Sales Estimate Current Quarter

1073

Average Sales Estimate Next Quarter

1105

Fair Value

132.15

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

78.5

Max Drawdown 5-Year %

-86.2

Target Price

135.32

P/E

21.34

Forward P/E

19.99

PEG

1.82

P/S

4.1

P/B

7.48

P/Free Cash Flow

17.78

EPS

5.45

Average EPS Est. Cur. Y

5.14

EPS Next Y. (Est.)

5.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.59

Relative Volume

1.08

Return on Equity vs Sector %

1.7

Return on Equity vs Industry %

18.7

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.07

EBIT Estimation

25.6

Illumina, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees:

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

stock quote shares ILMN – Illumina, Inc. Stock Price stock today

news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ILMN – Illumina, Inc. yahoo finance google finance

stock history ILMN – Illumina, Inc. invest stock market

stock prices ILMN premarket after hours

ticker ILMN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ILMN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y